Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston blog main
deals
2
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
2
×
san francisco top stories
sickle cell disease
2
×
startups
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
astrazeneca
azacitidine
beta-thalassemia
biogen
bluerock therapeutics
boston
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
clinical trials
covid-19
crispr
dacogen
decitabine
deerfield management
detroit blog main
detroit top stories
dna
What
medicines
2
×
acquisitions
aims
announced
approach
based
bio
biotech
called
ceo
collabs
covid
daniel
deal
debuts
developing
drugs
epigenetic
epigenetics
field
flagship’s
gilead
gilead’s
help
introduce
ipo
month
morning
new
omega
o’day
plans
research
roundup
sciences
startup
step
therapeutics
touting
transformative
Language
unset
Current search:
deals
×
medicines
×
" san francisco blog main "
×
biotech
×
" sickle cell disease "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further